Research published in Frontiers in Pediatrics provides clinical evidence that Evivo resolves gut dysbiosis in preterm infants. In an observational cohort study, infants born at less than 1500g and/or 34 weeks corrected gestational age were fed Evivo per hospital feeding protocol. Infants born at greater than 1500g and/or 34 weeks cga were not fed a probiotic. Despite the increased risk associated with extreme prematurity and lower birth weight, preterm infants in the Evivo-fed cohort had:
*Based on TNFa quantification
Only Evivo contains the essential beneficial bacteria, activated B. infantis EVC001. This proprietary strain is the first and only infant probiotic clinically proven to improve the biochemistry of the infant gut, reducing potential gut pathogens and improving human milk utilization. Only Evivo is shown to resolve gut dysbiosis, create a protective environment in the infant gut, and decrease enteric inflammation in infants.
Resolve Gut Dysbiosis and Improve Health Outcomes in NICU Infants
New research shows significant improvement in gut dysbiosis and enteric inflammation in neonates fed Evivo
REQUEST A SCIENTIFIC PRESENTATION
Get the latest updates.
* excluding Alaska , Hawaii and interternational
Evivo, a live beneficial bacteria, is shipped 2-day delivery to minimize time spent in warmer weather. But don’t worry, Evivo will withstand a wide range of temperatures through the hottest and coldest seasons!
Orders placed after 10:30 am PST Thursday through Sunday, ship the first business day the following week to ensure your Evivo does not sit in the carrier’s delivery truck or facility over the weekend. Overnight orders placed Monday through Thursday before 11:30 am PST ship the same day.
See our FAQs for more information about Orders, Shipping, & Evivo's Return Policy.
Fast. Free Shipping. Learn More.
Notify me when available